Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.39 |
| ▸ | PRKDC | P78527 | 5/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22756898 | 0.99 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL23239174 | 0.98 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL18655597 | 0.98 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL24919256 | 0.98 | ALOX5 (0.47) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL25823848 | 0.97 | ALOX5 (0.45) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL23238882 | 0.97 | ALOX5 (0.45) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL23238174 | 0.97 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL24919112 | 0.97 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL23237063 | 0.97 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2MCL1 | |
| SCHEMBL23238374 | 0.97 | ALOX5 (0.50) | ALOX5GGPS1PRKDCPTGES2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-15 | — | — | US | disclosed |
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-15 | — | — | US | disclosed |
| US-20230047512-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| EP-3747876-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co.,Ltd. (JP) | 2020-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | LEF1, TCF4, RPL19 | ALOX5 713/4885GGPS1 2567/4885PRKDC 4844/4885 |
| US-20230047512-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | LEF1, RPL19, ELP1 | ALOX5 861/4885GGPS1 2674/4885PRKDC 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.